Skip to main content
. 2014 Nov 10;143(4):651–660. doi: 10.1111/imm.12346

Figure 8.

Figure 8

Histone H3 lysine acetylation levels at the tumour necrosis factor-α (TNF-α) promoter of spleen with/without prenatal dexamethasone (DEX) treatment. Bar graphs showing (a) the total H3 lysine acetylation levels at different TNF-α promoters. (b) H3K9/K14 acetylation level of prenatal DEX group relative to vehicle at the TNF-α promoter 3. Chromatin immunoprecipitation assays were performed with H3K4/K9 acetylation antibody. Results were expressed as fold difference over vehicle (mean ± SEM; *P < 0·05; n = 6)